Insight Molecular Diagnostics (IMDX) Return on Equity [ROE] (2016 - 2025)
Insight Molecular Diagnostics (IMDX) recorded Return on Equity [ROE] of -1120.84% in Q2 2025, down 910.05 percentage points from -210.78% a year earlier.
Insight Molecular Diagnostics (IMDX) Return on Equity [ROE] (2016 - 2025) Analysis & Trends
For FY2024, Insight Molecular Diagnostics reported Return on Equity [ROE] of -1480.67%, down 1379.20 percentage points from FY2023.
- Annual Return on Equity [ROE] has a five-year change of -1349.76 percentage points (FY2019 to FY2024).
- Across earlier years, Return on Equity [ROE] came in at -101.46% in FY2023 (+45.06 pp), -146.52% in FY2022 (-16.64 pp), -129.88% in FY2021 (-36.95 pp) and -92.93% in FY2020 (+37.99 pp).
- The Q2 2025 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q1 2016.
- On a year-over-year basis, Return on Equity [ROE] rose in 1 of the last six quarters, with an average year-over-year change of -202.09 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 52.18 percentage points in Q2 2021, against a drop of 910.05 percentage points in Q2 2025 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 3.88% |
| 10 | Insight Molecular Diagnostics | 117.12 Mn | 40.83 Mn | 157,000.00 | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,120.84% |
| Sep 30, 2024 | -266.21% |
| Jun 30, 2024 | -210.78% |
| Mar 31, 2024 | -249.21% |
| Dec 31, 2023 | -98.15% |
| Sep 30, 2023 | -142.37% |
| Jun 30, 2023 | -146.23% |
| Mar 31, 2023 | -164.98% |
| Dec 31, 2022 | -131.18% |
| Sep 30, 2022 | -79.47% |
| Jun 30, 2022 | -97.11% |
| Mar 31, 2022 | -115.03% |
| Dec 31, 2021 | -77.66% |
| Sep 30, 2021 | -34.49% |
| Jun 30, 2021 | -26.59% |
| Mar 31, 2021 | -34.61% |
| Dec 31, 2020 | -88.81% |
| Sep 30, 2020 | -85.08% |
| Jun 30, 2020 | -78.77% |
| Mar 31, 2020 | -84.44% |
Insight Molecular Diagnostics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();